| Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapy J Lai-Kwon, S Heynemann, J Flore, H Dhillon, M Duffy, J Burke, L Briggs, ... Journal of Cancer Survivorship 15, 392-397, 2021 | 29 | 2021 |
| Alectinib induces marked red cell spheroacanthocytosis in a near-ubiquitous fashion and is associated with reduced eosin-5-maleimide binding JA Kuzich, S Heynemann, N Geoghegan, C Evelyn, S O'Mahoney, ... Pathology 53 (5), 608-612, 2021 | 15 | 2021 |
| Evolving Landscape of Metastatic Cancer Survivorship—Reconsidering Clinical Care, Policy, and Research Priorities for the Modern Era J Lai-Kwon, S Heynemann, NH Hart, RJ Chan, TJ Smith, L Nekhlyudov, ... Journal of Clinical Oncology, JCO. 22.02212, 2023 | 12 | 2023 |
| Risk factors associated with suicide in adolescents and young adults (AYA) with cancer S Heynemann, K Thompson, D Moncur, S Silva, M Jayawardana, J Lewin Cancer medicine 10 (20), 7339-7346, 2021 | 9 | 2021 |
| An exploration of the perceptions, experience and practice of cancer clinicians in caring for patients with cancer who are also parents of dependent-age children S Heynemann, J Philip, SA McLachlan Supportive Care in Cancer, 1-8, 2021 | 9 | 2021 |
| NaPi2b expression in a large surgical Non-Small Cell Lung Cancer (NSCLC) cohort S Heynemann, H Yu, L Churilov, G Rivalland, K Asadi, R Mosher, ... Clinical lung cancer 23 (2), e90-e98, 2022 | 7 | 2022 |
| Developments in systemic therapies for the management of lung cancer S Heynemann, P Mitchell Internal Medicine Journal 51 (12), 2012-2020, 2021 | 5 | 2021 |
| Supporting cancer care clinicians to ‘hold’their patients during and beyond the COVID‐19 pandemic: a role for reflective ethics discussions C Delany, J Benhamu, R McDougall, D Ko, H Jones, L Mileshkin, ... Internal Medicine Journal 51 (7), 1143-1145, 2021 | 5 | 2021 |
| When research becomes practice: the concept of the therapeutic misconception and challenges to consent in clinical trials S Heynemann, W Lipworth, SA McLachlan, J Philip, T John, I Kerridge Internal Medicine Journal 53 (2), 271-274, 2023 | 3 | 2023 |
| Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene‐addicted metastatic non‐small cell lung cancer (NSCLC) following … S Heynemann, V Vanguru, S Adelstein, S Kao Asia‐Pacific Journal of Clinical Oncology, 2022 | 1 | 2022 |
| Relevance of sun safety in patients commencing crizotinib for non-small cell lung cancer S Heynemann, P Mitchell The Australasian journal of dermatology 62 (2), e332-e333, 2021 | 1 | 2021 |
| Entanglements and imagined futures: The subject (s) of precision in oncology J Flore, R Kokanović, A Broom, S Heynemann, J Lai-Kwon, M Jefford Social Science & Medicine 317, 115608, 2023 | | 2023 |
| Squamous cell carcinoma differentiation at progression as a resistance mechanism in metastatic non-small cell lung carcinoma harbouring a targetable mutation S Heynemann, N Prosser, J Lee, A Mahar, L Anderson, S Kao, ... Pathology 54 (7), 935-938, 2022 | | 2022 |
| Junior doctors voice strong desire for clinical ethics teaching JA Schnall, G Drewett, S Heynemann, R McDougall, D Ko Internal Medicine Journal 52 (1), 160-161, 2022 | | 2022 |
| P39. 06 Surviving Metastatic Non-Small Cell Lung Cancer–Experience and Supportive Care Needs of Patients Receiving Novel Therapies S Heynemann, J Lai-Kwon, J Flore, H Dhillon, M Duffy, J Burke, L Briggs, ... Journal of Thoracic Oncology 16 (3), S468, 2021 | | 2021 |
| Surviving metastatic non-small cell lung cancer (mNSCLC): The lived experience and supportive care needs of patients (pts) receiving immunotherapy (IT) or targeted therapy (TT). JE Lai-Kwon, S Heynemann, J Flore, M Duffy, R Kokanovic, M Jefford Journal of Clinical Oncology 38 (15_suppl), e24185-e24185, 2020 | | 2020 |
| An exploration of the perceptions, experience and practice of cancer clinicians in caring for young patients with malignancy who are also parents S Heynemann, SA McLachlan, J Philip ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 15, 199-200, 2019 | | 2019 |
| The prevalence of bleeding disorders in women with proven endometriosis S Heynemann, C Barnes, R Dauer, SR Grover | | |
